Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis

Joel J. Bergh, Hung Yun Lin, Lawrence Lansing, Seema N. Mohamed, Faith B. Davis, Shaker Mousa, Paul J. Davis

Research output: Contribution to journalArticle

  • 360 Citations

Abstract

Integrin αVβ3 is a heterodimeric plasma membrane protein whose several extracellular matrix protein ligands contain an RGD recognition sequence. This study identifies integrin α Vβ3 as a cell surface receptor for thyroid hormone [L-T4 (T4)] and as the initiation site for T 4-induced activation of intracellular signaling cascades. Integrin αVβ3 dissociably binds radiolabeled T 4 with high affinity, and this binding is displaced by tetraiodothyroacetic acid, αVβ3 antibodies, and an integrin RGD recognition site peptide. CV-1 cells lack nuclear thyroid hormone receptor, but express plasma membrane αVβ 3; treatment of these cells with physiological concentrations of T4 activates the MAPK pathway, an effect inhibited by tetraiodothyroacetic acid, RGD peptide, and αVβ 3 antibodies. Inhibitors of T4 binding to the integrin also block the MAPK-mediated proangiogenic action of T4. T 4-induced phosphorylation of MAPK is inhibited by small interfering RNA knockdown of αV and β3. These findings suggest that T4 binds to αVβ3 near the RGD recognition site and show that hormone-binding to α Vβ3 has physiological consequences.

LanguageEnglish
Pages2864-2871
Number of pages8
JournalEndocrinology
Volume146
Issue number7
DOIs
Publication statusPublished - Jul 2005
Externally publishedYes

Fingerprint

Cell Surface Receptors
Mitogen-Activated Protein Kinases
Thyroid Hormones
Integrins
Cell Membrane
Integrin alpha Chains
Thyroid Hormone Receptors
Antibodies
Extracellular Matrix Proteins
Cytoplasmic and Nuclear Receptors
Thyroxine
Small Interfering RNA
Blood Proteins
Membrane Proteins
Phosphorylation
Hormones
Ligands
Peptides
tetraiodothyroacetic acid

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. / Bergh, Joel J.; Lin, Hung Yun; Lansing, Lawrence; Mohamed, Seema N.; Davis, Faith B.; Mousa, Shaker; Davis, Paul J.

In: Endocrinology, Vol. 146, No. 7, 07.2005, p. 2864-2871.

Research output: Contribution to journalArticle

Bergh, Joel J. ; Lin, Hung Yun ; Lansing, Lawrence ; Mohamed, Seema N. ; Davis, Faith B. ; Mousa, Shaker ; Davis, Paul J. / Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. In: Endocrinology. 2005 ; Vol. 146, No. 7. pp. 2864-2871.
@article{6b33235818b640b49a5d649687e6ad5b,
title = "Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis",
abstract = "Integrin αVβ3 is a heterodimeric plasma membrane protein whose several extracellular matrix protein ligands contain an RGD recognition sequence. This study identifies integrin α Vβ3 as a cell surface receptor for thyroid hormone [L-T4 (T4)] and as the initiation site for T 4-induced activation of intracellular signaling cascades. Integrin αVβ3 dissociably binds radiolabeled T 4 with high affinity, and this binding is displaced by tetraiodothyroacetic acid, αVβ3 antibodies, and an integrin RGD recognition site peptide. CV-1 cells lack nuclear thyroid hormone receptor, but express plasma membrane αVβ 3; treatment of these cells with physiological concentrations of T4 activates the MAPK pathway, an effect inhibited by tetraiodothyroacetic acid, RGD peptide, and αVβ 3 antibodies. Inhibitors of T4 binding to the integrin also block the MAPK-mediated proangiogenic action of T4. T 4-induced phosphorylation of MAPK is inhibited by small interfering RNA knockdown of αV and β3. These findings suggest that T4 binds to αVβ3 near the RGD recognition site and show that hormone-binding to α Vβ3 has physiological consequences.",
author = "Bergh, {Joel J.} and Lin, {Hung Yun} and Lawrence Lansing and Mohamed, {Seema N.} and Davis, {Faith B.} and Shaker Mousa and Davis, {Paul J.}",
year = "2005",
month = "7",
doi = "10.1210/en.2005-0102",
language = "English",
volume = "146",
pages = "2864--2871",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis

AU - Bergh, Joel J.

AU - Lin, Hung Yun

AU - Lansing, Lawrence

AU - Mohamed, Seema N.

AU - Davis, Faith B.

AU - Mousa, Shaker

AU - Davis, Paul J.

PY - 2005/7

Y1 - 2005/7

N2 - Integrin αVβ3 is a heterodimeric plasma membrane protein whose several extracellular matrix protein ligands contain an RGD recognition sequence. This study identifies integrin α Vβ3 as a cell surface receptor for thyroid hormone [L-T4 (T4)] and as the initiation site for T 4-induced activation of intracellular signaling cascades. Integrin αVβ3 dissociably binds radiolabeled T 4 with high affinity, and this binding is displaced by tetraiodothyroacetic acid, αVβ3 antibodies, and an integrin RGD recognition site peptide. CV-1 cells lack nuclear thyroid hormone receptor, but express plasma membrane αVβ 3; treatment of these cells with physiological concentrations of T4 activates the MAPK pathway, an effect inhibited by tetraiodothyroacetic acid, RGD peptide, and αVβ 3 antibodies. Inhibitors of T4 binding to the integrin also block the MAPK-mediated proangiogenic action of T4. T 4-induced phosphorylation of MAPK is inhibited by small interfering RNA knockdown of αV and β3. These findings suggest that T4 binds to αVβ3 near the RGD recognition site and show that hormone-binding to α Vβ3 has physiological consequences.

AB - Integrin αVβ3 is a heterodimeric plasma membrane protein whose several extracellular matrix protein ligands contain an RGD recognition sequence. This study identifies integrin α Vβ3 as a cell surface receptor for thyroid hormone [L-T4 (T4)] and as the initiation site for T 4-induced activation of intracellular signaling cascades. Integrin αVβ3 dissociably binds radiolabeled T 4 with high affinity, and this binding is displaced by tetraiodothyroacetic acid, αVβ3 antibodies, and an integrin RGD recognition site peptide. CV-1 cells lack nuclear thyroid hormone receptor, but express plasma membrane αVβ 3; treatment of these cells with physiological concentrations of T4 activates the MAPK pathway, an effect inhibited by tetraiodothyroacetic acid, RGD peptide, and αVβ 3 antibodies. Inhibitors of T4 binding to the integrin also block the MAPK-mediated proangiogenic action of T4. T 4-induced phosphorylation of MAPK is inhibited by small interfering RNA knockdown of αV and β3. These findings suggest that T4 binds to αVβ3 near the RGD recognition site and show that hormone-binding to α Vβ3 has physiological consequences.

UR - http://www.scopus.com/inward/record.url?scp=22144494707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144494707&partnerID=8YFLogxK

U2 - 10.1210/en.2005-0102

DO - 10.1210/en.2005-0102

M3 - Article

VL - 146

SP - 2864

EP - 2871

JO - Endocrinology

T2 - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 7

ER -